tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tejas Savant, 86 are a HOLD (37.89%), 15 are a SELL (6.61%), 126 are a BUY (55.51%).
Analyst Tejas Savant, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 45.68% that have a potential upside of 29.96% achieved within 150 days.
Tejas Savant’s has documented 516 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on NTRA, Natera at 02-Dec-2025.
Analyst best performing recommendations are on CTKB (CYTEK BIOSCIENCES).
The best stock recommendation documented was for CTKB (CYTEK BIOSCIENCES) at 2/29/2024. The price target of $9 was fulfilled within 1 day with a profit of $1.3 (16.88%) receiving and performance score of 168.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2020
$22
$5.96 (37.16%)
$19
11 days ago
(06-Feb-2026)
7/11 (63.64%)
$5.53 (33.58%)
82
Hold Since 09-Sep-2020
$16
$-0.04 (-0.25%)
$9
3 months 6 days ago
(11-Nov-2025)
8/8 (100%)
$1.47 (10.12%)
581
Buy Since 08-Aug-2023
$20
$3.96 (24.69%)
$15
4 months 2 days ago
(15-Oct-2025)
13/13 (100%)
$2.89 (16.89%)
269
Buy Since 21-Mar-2025
$10
$-6.04 (-37.66%)
$9
9 months 15 days ago
(02-May-2025)
5/6 (83.33%)
$0.16 (1.63%)
96
Buy Since 05-Jan-2023
$12
$-4.04 (-25.19%)
$15
1 years 4 days ago
(13-Feb-2025)
2/2 (100%)
$3.48 (40.85%)
570
Which stock is Tejas Savant is most bullish on?
Which stock is Tejas Savant is most reserved on?
What Year was the first public recommendation made by Tejas Savant?
